Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.3.5.1 (
succinate dehydrogenase
)
8,177
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Studies have shown that monomers from dental resins are acutely cytotoxic, but little is known of their long-term effects at sub-lethal concentrations. The current study determined the long-term effects of sub-lethal concentrations of TEGDMA (triethyleneglycol dimethacrylate) and
Bis-GMA
(bisphenol-glycidylinethacrylate), two common dental monomers, on the in vitro cellular proliferation,
succinic dehydrogenase
activity, and total cellular protein production of monocytes. Human THP-1 monocytes were exposed to concentrations of 100, 200, and 400 micromol l(-1) of TEGDMA or 1, 5, and 25 micromol l(-1)
Bis-GMA
for 5 weeks. Controls received only vehicle solutions of ethanol. Each week cellular proliferation (hemocytometer),
succinic dehydrogenase
(
SDH
) activity (MTT) and total cellular protein (bicinchoninic acid) were assessed. The results were compared with ANOVA and Tukey intervals (alpha = 0.05). TEDGMA had no proliferative or cellular protein effects, but increased
SDH
activity 20-60% in week 1 (p < 0.05).
SDH
activity then decreased 40% in week 2, followed by a gradual increase of 30-40% over week 3-5 (p < 0.05).
Bis-GMA
reduced proliferation by 40-60% from 1-5 weeks exposure (p < 0.05). However,
SDH
activity and total protein per cell were not affected. There was some indication of increased
SDH
activity after 5 weeks (20-30%, p < 0.05). Sub-lethal concentrations of TEGDMA and
Bis-GMA
have significant long-term effects on monocytes at low-dose 5-week exposures in vitro. Each monomer acted differently.
...
PMID:Effects of long-term sub-lethal concentrations of dental monomers on THP-1 human monocytes. 1067 21